Publications by authors named "Neil Inhaber"

Claim this Profile
C
Clinical validity of dried blood spot assay for the measurement of functional C1 inhibitor in angioedema due to C1 inhibitor deficiency.
Jonathan A Bernstein, Jie Cheng, Thomas Pisani, Dan Sexton, Rachel E Whitaker, Neil Inhaber

J Allergy Clin Immunol Glob· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France.
Olivier Fain, Aurelie Du-Thanh, Delphine Gobert, David Launay, Neil Inhaber

Allergy Asthma Clin Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.
Aleena Banerji, Jonathan A Bernstein, Douglas T Johnston, William R Lumry, Markus Magerl, Neil Inhaber

Allergy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study.
Douglas T Johnston, Paula J Busse, Marc A Riedl, Marcus Maurer, John Anderson, Neil Inhaber

Clin Exp Allergy· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HAE patient self-sampling for biomarker establishment.
Toni M Förster, Markus Magerl, Marcus Maurer, Selen Zülbahar, Susanne Zielke, Neil Inhaber

Orphanet J Rare Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust multiplexed assay to quantify C1-inhibitor, C1q, and C4 proteins for in vitro diagnosis of hereditary angioedema from dried blood spot.
Yongquan Lai, Guodong Zhang, Neil Inhaber, Jonathan A Bernstein, Michael Cwik

J Pharm Biomed Anal· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel functional C1 inhibitor activity assay in dried blood spot for diagnosis of Hereditary angioedema.
Yongquan Lai, Guodong Zhang, Zhiwei Zhou, Neil Inhaber, Jonathan A Bernstein

Clin Chim Acta· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949].
Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Neil Inhaber

J Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949].
Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Neil Inhaber

J Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Neil Inhaber

J Hepatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
Charles F P George, Neil Feldman, Yanping Zheng, Teresa L Steininger, Susanna M Grzeschik, Neil Inhaber

Sleep Breath· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma.
Jill Karpel, Marc Massanari, Gregory P Geba, Farid Kianifard, Neil Inhaber

Ann Allergy Asthma Immunol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Jed Black, Daniel Pardi, Carl S Hornfeldt, Neil Inhaber

J Clin Sleep Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study.
Harvey Moldofsky, Neil H Inhaber, Diane R Guinta, Sarah B Alvarez-Horine

J Rheumatol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.
Charles F P George, Neil Feldman, Neil Inhaber, Teresa L Steininger, Susanna M Grzeschik

Sleep Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Jed Black, Daniel Pardi, Carl S Hornfeldt, Neil Inhaber

Sleep Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis